Phase II Study of XELOX and Cetuximab as First Line Therapy in Patients with Wild Type KRAS Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2016
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FLEET-2
- 01 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Jun 2012 Additional lead investigator(Hideyuki Mishima) identified as reported by University Hospital Medical Information Network - Japan record.
- 07 Feb 2012 New trial record